http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-94030499-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e493dbb326bdb84242fbc9af833f128e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 1992-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb80263932d332068d8651e84b31e925 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e75e453e98782aaf043c9292b5888c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99447ae13a5c7211be616b2f6e986163 |
| publicationDate | 1996-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-94030499-A |
| titleOfInvention | Tetrahydroisoquinoline compounds, their o-acylated derivatives, method of synthesis, pharmaceutical composition, method of treatment |
| abstract | Tetrahydroisoquinoline compounds of the formula I and their pharmaceutically acceptable salts, in which: R represents one or more substituents selected from H, halogen, hydroxy, alkyl (optionally substituted hydroxy), alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, nitro, cyano, polyhaloalkyl, polygaloalkyl phenyl (optionally substituted with one or more halogen, alkyl or alkoxy), or R is carbonyl optionally substituted with carbomoyl; R represents an aliphatic group optionally substituted with hydroxy or alkoxy; E represents an alkylene chain optionally substituted with one or more alkyl groups; G is phenyl or phenyl substituted with one or more alkyl, alkoxy, halogen, hydroxy, polyhaloalkyl, polyhaloalkoxy cyano, alkylthio, alkylsulfinyl, alkylsulfonyl, phenyl (optionally substituted with one or more halogen, alkyl or alkoxy), optionally alkyl carbomoyl or G represents a phenyl ring having a heterocyclic or aromatic ring fused to it; 0 - acylated derivatives representing lyophilic esters, which are used in analgesia and in the treatment of psychoses (e.g. schizophrenia), Parkinson's disease, Lesch-Nyan syndrome, impaired attention deficit or impaired cognitive ability, or to alleviate drug dependence or delayed dyskinesia. |
| priorityDate | 1991-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.